Literature DB >> 14660

Comparative potencies and beta2-adrenoreceptor selectivities of rimiterol and salbutamol aerosols.

G E Marlin, B J Hartnett, N Berend.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 14660      PMCID： PMC1428978          DOI： 10.1111/j.1365-2125.1977.tb00671.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  10 in total

1.  Intravenous treatment with rimiterol and salbutamol in asthma.

Authors:  G E Marlin; P Turner
Journal:  Br Med J       Date:  1975-06-28

2.  The relative potencies and beta2-selectivities of intravenous rimiterol, salbutamol and isoprenaline in asthmatic patients.

Authors:  G E Marlin; P Turner
Journal:  Int J Clin Pharmacol Biopharm       Date:  1975-07

3.  Comparison of the bronchodilatory action of two drugs.

Authors:  F J Prime; P L Kamburoff; W Günthner
Journal:  Int Z Klin Pharmakol Ther Toxikol       Date:  1971-12

4.  A comparison of isoprenaline, salbutamol, and rimiterol inhalation on skin temperature, heart rate, and respiration in man.

Authors:  E M Phillips; M Woolnough; V M Marinova; P Turner
Journal:  J Clin Pharmacol New Drugs       Date:  1972-04

5.  The effect of a new adrenergic beta 2 -receptor-stimulating agent (rimiterol, R798) in patients with chronic obstructive lung disease.

Authors:  N Svedmyr; R Malmberg; G Thiringer
Journal:  Scand J Respir Dis       Date:  1972

6.  Preliminary studies of a new bronchodilator (WG 253) in man.

Authors:  J P Griffin; P Turner
Journal:  J Clin Pharmacol New Drugs       Date:  1971 Jul-Aug

7.  Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma.

Authors:  D A Warrell; D G Robertson; J N Howes; M E Conolly; J W Paterson; L J Beilin; C T Dollery
Journal:  Br Med J       Date:  1970-01-10

8.  Clinical assessment of bronchodilator drugs delivered by aerosol.

Authors:  G M Shenfield; J W Paterson
Journal:  Thorax       Date:  1973-03       Impact factor: 9.139

9.  Comparison of the beta2-adrenoceptor selectivity of rimiterol, salbutamol and isoprenaline by the intravenous route in man.

Authors:  G E Marlin; P Turner
Journal:  Br J Clin Pharmacol       Date:  1975-02       Impact factor: 4.335

10.  Comparison between the bronchodilator and cardiovascular effects of inhaling 0.5 mg. rimiterol ('Pulmadil') and 0.2 mg. salbutamol.

Authors:  S Bianco; P L Kamburoff; F J Prime
Journal:  Curr Med Res Opin       Date:  1975       Impact factor: 2.580
  10 in total
  3 in total

Review 1.  Rimiterol: a review of its pharmacological properties and therapeutic efficacy in asthma.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-08       Impact factor: 9.546

2.  Effect of intravenous injection of rimiterol in asthma.

Authors:  R A Tarala; V Martyn; J W Paterson
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

3.  Dose-titration comparison of inhaled salbutamol and oral theophylline in asthma.

Authors:  G E Marlin; M R Harris; J A Klumpp; J Rutland
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.